Buprenorphine for Prescription Opioid Addiction in a Patient With Depression and Alcohol Dependence
Another (3) showed that approximately 1.7 million Americans had a past-year prescription opioid use disorder, second only to cannabis use disorder.\n Office-based treatment also provides the opportunity to integrate addiction treatment into mainstream health care, shift away from an acute care model...
Gespeichert in:
Veröffentlicht in: | The American journal of psychiatry 2011-07, Vol.168 (7), p.675-679 |
---|---|
Hauptverfasser: | , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Another (3) showed that approximately 1.7 million Americans had a past-year prescription opioid use disorder, second only to cannabis use disorder.\n Office-based treatment also provides the opportunity to integrate addiction treatment into mainstream health care, shift away from an acute care model to one that is "disease management" oriented, and accelerate a broader adoption of pharmacotherapies into broader addiction treatment. Buprenorphine as part of a comprehensive medication-assisted recovery approach--combined, for example, with counseling, treatment of additional nonopioid substance use disorders, and treatment of comorbid psychiatric illness--provides an important tool for relapse prevention and should be a mainstay of the standard repertoire for treating opioid dependence. |
---|---|
ISSN: | 0002-953X 1535-7228 |
DOI: | 10.1176/appi.ajp.2010.10060879 |